<!doctype html>
<html class="no-js" lang="en">

<head>
  <!-- Global site tag (gtag.js) - Google Analytics -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=UA-134931760-1"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'UA-134931760-1');
  </script>

  <meta charset="utf-8">
  <meta http-equiv="x-ua-compatible" content="ie=edge">
  <title>Clinical trials have shown a decrease in Alzheimer's disease progression by more than half</title>
  <link rel="icon" type="image/x-icon" href="/favicon.ico" />
  <meta name="description" content="Phase III clinical trials in patients with mild to moderate Alzheimer's disease have more than halved the progression of the disease. Therapy included...">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

  <link rel="stylesheet" href="../../css/main.css">

  <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>
  <script>window.jQuery || document.write('<script src="../../js/vendors/jquery-3.3.1.min.js"><\/script>')</script>

  <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  <script>
       (adsbygoogle = window.adsbygoogle || []).push({
            google_ad_client: "ca-pub-6974184241884155",
            enable_page_level_ads: true
       });
  </script>
</head>

<body>
  <!--[if lte IE 9]>
    <p class="browserupgrade">You are using an <strong>outdated</strong> browser. Please <a href="https://browsehappy.com/">upgrade your browser</a> to improve your experience and security.</p>
  <![endif]-->
  <header class="page-header js-page-header">
    <a class="page-header-logo-container" href="https://weekly-geekly.github.io/index.html"></a>
    <div class="page-header-text">Geekly Articles each Day</div>
  </header>
  <nav class="page-headings-container js-page-headings-container"></nav>
  <div class="tools-bar js-tools-bar">
    <!-- <a href="../../search.html" title="Search">üîé</a> -->
    <a class="js-list-of-headings-button" data-state="closed" href="#" title="Headings">üìú</a>
    <a class="js-go-to-top-button" href="#" title="Go to Top">‚¨ÜÔ∏è</a>
    <a class="js-go-to-bottom-button" href="#" title="Go to Bottom">‚¨áÔ∏è</a>
  </div>
  <a href="http://bit.ly/donateToWeeklyGeekly" class="donate-btn">DONATE</a>
  <section class="page js-page"><h1>Clinical trials have shown a decrease in Alzheimer's disease progression by more than half</h1><div class="post__text post__text-html js-mediator-article"><img src="https://habrastorage.org/webt/5c/f6/zb/5cf6zbwihgphyqosi1isax9vp3k.jpeg"><br><br><blockquote>  Phase III clinical trials in patients with mild to moderate <a href="https://en.wikipedia.org/wiki/Alzheimer%2527s_disease">Alzheimer's disease</a> have more than halved the progression of the disease.  Therapy included removal of Œ≤-amyloid from the blood, not from the brain.  The levels of <a href="https://en.wikipedia.org/wiki/Amyloid_beta">Œ≤-amyloid</a> are dynamic, and there is a balance between its amount in the brain and in the blood.  <a href="https://www.fightaging.org/archives/2016/05/the-possibility-of-reducing-amyloid-in-the-brain-by-reducing-it-elsewhere">Past trials</a> have shown that reducing the level of Œ≤-amyloid in the blood can reduce its presence in the brain, which is the result of a new equilibrium. </blockquote><br>  The test seems to be an important confirmation of the <a href="https://en.wikipedia.org/wiki/Biochemistry_of_Alzheimer%2527s_disease">amyloid hypothesis</a> of Alzheimer's disease, just at the time of its intense criticism.  The history of unsuccessful attempts to reduce Œ≤-amyloid levels led to a variety of competing initiatives and increased attention to <a href="https://en.wikipedia.org/wiki/Neurofibrillary_tangle">tau aggregation</a> as the main cause of pathology in the later stages of the disease.  I also see in the test some signs in favor of the concept of <a href="https://www.fightaging.org/archives/2018/08/undoing-aging-doug-ethells-presentation-on-the-leucadia-therapeutics-approach-to-treating-alzheimers-disease">impaired filtration of CSF in the brain</a> .  In it, the ways in which <a href="https://en.wikipedia.org/wiki/Cerebrospinal_fluid">CSF</a> leaves the brain atrophy with age, and the rate of cleaning of metabolic debris decreases. <br><a name="habracut"></a><br>  <a href="https://clinicaltrials.gov/ct2/show/NCT01561053">Alzheimer Management by Albumin Replacement (AMBAR)</a> is an international, multi-center, <a href="https://en.wikipedia.org/wiki/Randomized_experiment">randomized</a> , <a href="https://en.wikipedia.org/wiki/Blinded_experiment">blind</a> , <a href="https://en.wikipedia.org/wiki/Placebo-controlled_study">placebo-controlled</a> , parallel group clinical trial involving Alzheimer's and <a href="https://clinicaltrials.gov/ct2/show/NCT01561053">Mild</a> Patients from 41 centers in Europe and the United States.  The purpose of the test was to evaluate the efficacy and safety of short-term <a href="https://en.wikipedia.org/wiki/Blood_plasma">plasma</a> replacement, and then long-term <a href="https://en.wikipedia.org/wiki/Plasmapheresis">plasmapheresis</a> with injections of <a href="https://en.wikipedia.org/wiki/Albumin">human albumin</a> in combination with intravenous infusion of <a href="https://en.wikipedia.org/wiki/Immunoglobulin">immunoglobulin</a> in patients with mild and moderate Alzheimer's disease. <br><br>  AMBAR is based on the hypothesis that most Œ≤-amyloid accumulated in the brain of Alzheimer's patients is bound to albumin and circulates in plasma.  Removing this plasma can lead to the migration of Œ≤-amyloid from the brain to the plasma, which reduces the effect of the disease on the cognitive functions of the patient.  In addition, albumin can be a comprehensive approach to the treatment of the disease due to its binding ability, antioxidant, immunomodulating and anti-inflammatory properties. 
      <br>
        <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
        <ins class="adsbygoogle"
          style="display:block; text-align:center;"
          data-ad-layout="in-article"
          data-ad-format="fluid"
          data-ad-client="ca-pub-6974184241884155"
          data-ad-slot="8945601208"></ins>
        <script>
          (adsbygoogle = window.adsbygoogle || []).push({});
        </script>
      <br>
      The AMBAR trial included 496 patients with mild and moderate Alzheimer's disease, randomized in the three treated groups and one <a href="https://en.wikipedia.org/wiki/Scientific_control">placebo group</a> .  The participants were 55-85 years old, and the effectiveness of the treatment was measured by changes in cognition and in terms of daily life.  An independent research organization (CRO) controlled the clinical trial and the steps of collecting and analyzing information.  Randomized and <a href="https://en.wikipedia.org/wiki/Blind_experiment">double-blind controls</a> were used in the trial, which meant that patients, doctors, and examiners did not know whether the patients used treatment or placebo. <br><br>  AMBAR analyzes have shown positive, very relevant results in patients with moderate Alzheimer's disease.  Doctors found a reduction in progression of 50-75% in the cognitive scale of Alzheimer's disease ( <a href="https://doi.org/10.1007/s11682-012-9166-3">ADAS-Cog</a> ) and 42-70% in the scale of daily living ( <a href="https://doi.org/10.1007/978-0-387-79948-3_1791">ADCS-ADL</a> ) in patients receiving treatment.  Including all patients receiving plasma replacement, the difference was 66% for the ADAS-Cog scale and 52% for the ADCS-ADL scale. <br><br>  <a href="https://www.grifols.com/en/view-news/-/new/grifols-ambar-results-demonstrate-a-significant-reduction-in-the-progression-of-moderate-alzheimers-disease">www.grifols.com/en/view-news/-/new/grifols-ambar-results-demonstrate-a-significant-reduction-in-the-progression-of-moderate-alzheimers-disease</a> </div><p>Source: <a href="https://habr.com/ru/post/428540/">https://habr.com/ru/post/428540/</a></p>
<section class="more-articles-navigation-panel js-more-articles-navigation-panel">
<h4>More articles:</h4>
<nav class="list-of-articles-container js-list-of-articles-container"><ul class="list-of-pages js-list-of-pages">
<li><a href="../428530/index.html">The results of the investigation of the accident "Union MS-10"</a></li>
<li><a href="../428532/index.html">HyperloopTT plans to launch the first Hyperloop branch in the 3rd quarter of 2019</a></li>
<li><a href="../428534/index.html">3D drilling machine and PCAD to G-Code drilling card converter</a></li>
<li><a href="../428536/index.html">Yandex.Meteum - technology without technology. Marketing accurate to the district</a></li>
<li><a href="../428538/index.html">EEG-headset - a gadget for music and the correction of emotions</a></li>
<li><a href="../428542/index.html">Tourists in the European Union will be checked using AI</a></li>
<li><a href="../428544/index.html">Vulnerability in Bluetooth opens up opportunities to attack wireless access points</a></li>
<li><a href="../428546/index.html">Three years of those. support, 152 health facilities, 3740 pcs</a></li>
<li><a href="../428548/index.html">Aspect-oriented programming, Spring AOP</a></li>
<li><a href="../428550/index.html">Inverter with a pure sine in 15 minutes or ‚Äúpower electronics for everyone‚Äù</a></li>
</ul></nav>
</section><br />
<a href="../../allArticles.html"><strong>All Articles</strong></a>
<script src="../../js/main.js"></script>

<!-- Yandex.Metrika counter -->
<script type="text/javascript" >
  (function (d, w, c) {
      (w[c] = w[c] || []).push(function() {
          try {
              w.yaCounter52496797 = new Ya.Metrika({
                  id:52496797,
                  clickmap:true,
                  trackLinks:true,
                  accurateTrackBounce:true,
                  webvisor:true
              });
          } catch(e) { }
      });

      var n = d.getElementsByTagName("script")[0],
          s = d.createElement("script"),
          f = function () { n.parentNode.insertBefore(s, n); };
      s.type = "text/javascript";
      s.async = true;
      s.src = "https://mc.yandex.ru/metrika/watch.js";

      if (w.opera == "[object Opera]") {
          d.addEventListener("DOMContentLoaded", f, false);
      } else { f(); }
  })(document, window, "yandex_metrika_callbacks");
</script>
<noscript><div><img src="https://mc.yandex.ru/watch/52496797" style="position:absolute; left:-9999px;" alt="" /></div></noscript>

<!-- Google Analytics -->
  <script>
    window.ga = function () { ga.q.push(arguments) }; ga.q = []; ga.l = +new Date;
    ga('create', 'UA-134931760-1', 'auto'); ga('send', 'pageview')
  </script>
  <script src="https://www.google-analytics.com/analytics.js" async defer></script>

</section>

  <footer class="page-footer">
    <div class="page-footer-legal-info-container page-footer-element">
      <p>
        Weekly-Geekly | <span class="page-footer-legal-info-year js-page-footer-legal-info-year">2019</span>
      </p>
    </div>
    <div class="page-footer-counters-container page-footer-element">
      <a class="page-footer-counter-clustrmap" href='#'  title='Visit tracker'><img src='https://clustrmaps.com/map_v2.png?cl=698e5a&w=271&t=t&d=6iCFw7uJz0zcOaoxz5k5PcLCJUzv2WG8G5V8M3U6Rc4&co=3a3a3a&ct=ffffff'/></a>
    </div>
  </footer>
</body>

</html>